Psychopharmacology

, Volume 113, Issue 3–4, pp 369–377

An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats

  • S. J. Kitchener
  • C. T. Dourish
Original Investigations

Abstract

Previous studies have shown that administration of 5-HT1B, 5-HT1C or 5-HT2 agonists decreases food intake in rats. However, it has not been established whether these drugs induce satiety or decrease feeding by a non-specific mechanism. In the present study the post-prandial satiety sequence was used to characterise the actions of the 5-HT2 receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), the 5-HT1B/5-HT1C receptor agonists, 1-(3-chorophenyl) piperazine (mCPP) and 1-[3-(trifluoromethyl)phenyl] piperazine (TFMPP), and the 5-HT1B agonist, 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)H-indole (RU 24969), on feeding in rats. All four compounds reduced food intake in rats that had been food deprived overnight. The 5-HT1B/5-HT1C agonists, TFMPP (at a dose of 1.0 mg/kg) and mCPP (at a dose of 3.0 mg/kg), appeared to produce satiety as their effects on the satiety sequence were similar to those induced by a food pre-load. In contrast, the 5-HT1B agonist RU 24969 and the 5-HT2 agonist DOI did not produce behavioural profiles that resembled satiety. Thus, RU 24969 elevated active behaviours and did not accelerate resting whereas DOI appeared to induce hypophagia by a non-specific fragmentation of behaviour. The results suggest that simultaneous activation of 5-HT1B and 5-HT1C receptors may be sufficient to elicit behaviourally specific satiety in the rat. In contrast, selective activation of 5-HT2 receptors does not induce satiety but elicits active behaviours and decreases feeding by response competition.

Key words

5-HT1B 5-HT1C 5-HT2 receptors Feeding Satiety sequence Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antin J, Gibbs J, Young RC, Smith GP (1975) Cholecystokinin elicits the complete behavioural sequence of satiety in rats. J Comp Physiol Psychol 89:784–790PubMedGoogle Scholar
  2. Bendotti C, Samanin R (1987) The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats. Life Sci 41:635–642CrossRefPubMedGoogle Scholar
  3. Blundell JE (1977) Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obesity 1:15–42Google Scholar
  4. Blundell JE, McArthur RA (1981) Behavioural flux and feeding: continuous monitoring of food intake and food selection and the video recording of appetitive and satiety sequences for the analysis of drug action. In: Garattini S, Samanin R (eds) Anorectic agents: mechanisms of action and tolerance. Raven, New York, pp 19–43Google Scholar
  5. Bradley PB, Engel G, Feniuk W, Fozard JH, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576CrossRefPubMedGoogle Scholar
  6. Clifton PG, Barnfield AMC, Philcox L (1989) A behavioural profile of fluoxetine-induced anorexia. Psychopharmacology 97:89–95Google Scholar
  7. Dourish CT (1992) 5-HT receptor subtypes and feeding behaviour. In: Bradley PB, Handley SL, Cooper SJ, Key BJ, Barnes NM, Coote JH (eds) Serotonin, CNS receptors and brain function, Pergamon, New York, pp 179–202Google Scholar
  8. Dourish CT, Hutson PH, Curzon G (1985a) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86:197–204CrossRefPubMedGoogle Scholar
  9. Dourish CT, Hutson PH, Curzon G (1985b) Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) Brain Res Bull 15:377–384CrossRefPubMedGoogle Scholar
  10. Dourish CT, Clark ML, Fletcher A, Iversen SD (1989a) Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats. Psychopharmacology 97:54–58Google Scholar
  11. Dourish CT, Rycroft W, Iversen SD (1989b) Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245:1509–1511PubMedGoogle Scholar
  12. Fletcher PJ, Ming ZH, Zack MH, Coscina DV (1992) A comparison of the effects of the 5-HT1 agonists TFMPP and RU 24969 on feeding following peripheral or medial hypothalamic injection. Brain Res 580:265–272CrossRefPubMedGoogle Scholar
  13. Fuller RW, Snoddy HD, Mason NR, Hemrick-Luecke SK, Clemens JA (1981) Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine andm-trifluoromethylphenyl-piperazine. J. Pharmacol Exp Ther 218:636–641PubMedGoogle Scholar
  14. Glennon RA (1986) Discriminative simulative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) Life Sci 39:825–830CrossRefPubMedGoogle Scholar
  15. Green AR, Guy AP, Gardner CR (1984) The behavioural effects of RU 24969, a suggested 5-HT receptor agonist in rodents, and the effect on the behaviour of treatment with antidepressants. Neuropharmacology 23:655–661CrossRefPubMedGoogle Scholar
  16. Hamon M, Cossery JM, Spampinato U, Gozlan H (1986) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in the brain? TIPS 7:336–338Google Scholar
  17. Heuring RE, Peroutka SJ (1987) Characterisation of a novel [3H]-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–890PubMedGoogle Scholar
  18. Hutson PH, Dourish CT, Curzon G (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur J Pharmacol 129:347–352CrossRefPubMedGoogle Scholar
  19. Hutson PH, Donohoe TP, Curzon G (1988) Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95:550–552Google Scholar
  20. Kennett GA, Curzon G (1988a) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147PubMedGoogle Scholar
  21. Kennett GA, Curzon G (1988b) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology 96:93–100Google Scholar
  22. Kennett GA, Curzon G (1988c) The antiemetic drug trimethoben-zamide prevents hypophagia due to acetyl salicyclate, but not to 5-HT1B or 5-HT1C agonists. Psychopharmacology 96:101–103Google Scholar
  23. Kennett GA, Dourish CT, Curzon G (1987a) 5-HT1B agonists induce anorexia at a post-synaptic site. Eur J Pharmacol 141:429–435CrossRefPubMedGoogle Scholar
  24. Kennett GA, Marcon M, Dourish CT, Curzon G (1987b) Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol 138:53–60CrossRefPubMedGoogle Scholar
  25. Levine LR, Rosenblatt S, Bosomworth J (1987) Use of a serotonin reuptake inhibitor, fluoxetine, in the treatment of obesity. Int J Obesity 11 [Suppl. 3]:185–190Google Scholar
  26. Montgomery AJM, Willner P (1988) Fenfluramine disrupts the behavioural satiety sequence in rats. Psychopharmacology 94:397–401Google Scholar
  27. Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur J Pharmacol 106:359–546Google Scholar
  28. Pedigo NE, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone. J Neurochem 36:220–226PubMedGoogle Scholar
  29. Rowland NE, Carlton J (1986) Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27:13–62CrossRefPubMedGoogle Scholar
  30. Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163CrossRefGoogle Scholar
  31. Schechter LE, Simansky KJ (1988) 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology 94:342–346PubMedGoogle Scholar
  32. Simansky KJ, Vaidya AH (1990) Behavioural mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res Bull 25:953–960CrossRefPubMedGoogle Scholar
  33. Tricklebank MD, Middlemiss DN, Neill J (1986) Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist RU 24969 in the rat. Neuropharmacology 25:877–886CrossRefPubMedGoogle Scholar
  34. Wilkinson LO, Dourish CT (1991) Serotonin and animal behaviour. In: Peroutka SJ (ed) Serotonin receptor subtypes: basic and clinical aspects. Liss, New York, pp 149–212Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • S. J. Kitchener
    • 1
  • C. T. Dourish
    • 1
  1. 1.Merck Sharp & Dohme Research LaboratoriesNeuroscience Research CentreHarlowUK
  2. 2.Dept. of Neuropharmacology, Wyeth Research (UK) LtdMaidenheadUK

Personalised recommendations